Page 48 - Access Pool News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Print COVID-19 vaccines were still in the early stages of development last spring, but Costa Rican President Carlos Alvarado Quesada was thinking ahead. Even if those efforts were successful, he figured, wealthy nations alone wouldn’t be able to make enough vaccine to quickly inoculate billions of people. His solution: a program, launched by the World Health Organization last May that aimed to train dozens of pharmaceutical manufacturers in Latin America, Asia and Africa to increase worldwide production of vaccines once they came on the market. But the effort, known as the COVID-19 Techno...

Developing countries are dealing with a shortage of coronavirus vaccines, with the hoarding of supply and the protection of intellectual property in affluent nations two reasons why.

US Senators ask vaccine companies to share supply plans for India, world SECTIONS Share Synopsis They have suggested that the companies share their vaccine technology and manufacturing information with other companies to speed up production. AP If this proposal goes through, it would temporarily lift certain intellectual property barriers and allow countries to locally manufacture Covid-19 diagnostics, treatments, and vaccines, the senators said. Five US senators led by Elizabeth Warren have written to drug makers Moderna, Pfizer and Johnson & Johnson, asking them to provide details on the ...

An amendment calling on the EU to back India and South Africa’s proposal to temporary lift intellectual property rights for the COVID-19 vaccine was rejected by the European Parliament on Thursday (29 April). The question of suspending IP rights for COVID-19 treatments and vaccines was first tabled by India and South Africa in a proposal to the World Trade Organization (WTO) which was backed by around 100 other countries. According to the proponents, an IP waiver for vaccine patents could speed up vaccine access in poorer countries. The waiver would cover obligations in four sections of t...

More than 60 people protested outside Moderna’s headquarters in Cambridge on Wednesday to demand expanded global access to COVID-19 vaccines as the virus runs rampant in India, and Massachusetts’ two US senators expressed support for expanded international availability.